​

Hemab Therapeutics Holdings Ownership | Who Owns Hemab Therapeutics Holdings?


OverviewFinancialsChartTranscripts

Hemab Therapeutics Holdings Ownership Summary


Hemab Therapeutics Holdings is owned by 120.52% institutional investors, 10.78% insiders. Ra capital management is the largest institutional shareholder, holding 25.93% of COAG shares. American Funds SMALLCAP World A is the top mutual fund, with 7.51% of its assets in Hemab Therapeutics Holdings shares.

COAG Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHemab Therapeutics Holdings120.52%10.78%-31.30%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management7.81M25.93%$286.81M
Novo4.18M13.88%$153.55M
Fmr3.72M12.36%$114.80M
Deep track capital, lp3.60M11.96%$132.30M
Capital investors3.60M11.96%$111.07M
Siren2.37M7.86%$72.97M
Avoro capital advisors1.93M6.39%$70.71M
Bain capital life sciences investors1.65M5.48%$60.60M
Jpmorgan chase932.86K3.10%$30.41M
State street927.25K3.08%$28.60M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Novo4.18M8.92%$153.55M
Bain capital life sciences investors1.65M3.60%$60.60M
Ra capital management7.81M2.49%$286.81M
Deep track capital, lp3.60M1.93%$132.30M
Siren2.37M1.72%$72.97M
Rock springs capital management lp575.43K1.03%$21.14M
Avoro capital advisors1.93M0.64%$70.71M
Bellevue group550.00K0.43%$20.20M
Affinity asset advisors138.03K0.23%$5.07M
Braidwell lp160.00K0.22%$5.88M

Top Buyers

HolderShares% AssetsChange
Ra capital management7.81M2.49%7.81M
Novo4.18M8.92%4.18M
Deep track capital, lp3.60M1.93%3.60M
Avoro capital advisors1.93M0.64%1.93M
Bain capital life sciences investors1.65M3.60%1.65M

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase932.86K0.00%-219.56K
Abrdn---52.12K
Ensign peak advisors96.45K0.00%-18.95K
Landscape capital management---13.18K
Squarepoint ops---6.25K

New Positions

HolderShares% AssetsChangeValue
Ra capital management7.81M2.49%7.81M$286.81M
Novo4.18M8.92%4.18M$153.55M
Deep track capital, lp3.60M1.93%3.60M$132.30M
Avoro capital advisors1.93M0.64%1.93M$70.71M
Bain capital life sciences investors1.65M3.60%1.65M$60.60M

Sold Out

HolderChange
Squarepoint ops-6.25K
Landscape capital management-13.18K
Abrdn-52.12K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202656-36,291,239-120-56---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A3.51M7.51%-
Fidelity Growth Compy Commingled Pl S691.58K1.48%-
Vanguard Morn Total Stk Mkt Idx Investor555.54K1.19%523.56K
Vanguard MStar Total Stk Mkt Idx Invest555.54K1.19%-
State Street® SPDR® S&P® Biotech ETF552.48K1.18%14.45K
Fidelity Growth Company Fund523.85K1.12%-
iShares Russell 2000 ETF501.67K1.07%-
Fidelity Select Biotechnology439.48K0.94%-
JPMorgan Small Cap Growth A426.26K0.91%-16.72K
Fidelity Stock Selector Small Cap383.45K0.82%-56.50K

Insider Transactions Trends


DateBuySell
2026 Q3--

COAG Ownership FAQ


Who Owns Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings shareholders are primarily institutional investors at 120.52%, followed by 10.78% insiders and -31.30% retail investors. The average institutional ownership in Hemab Therapeutics Holdings's industry, Biotech Stocks , is 385.89%, which Hemab Therapeutics Holdings falls below.

Who owns the most shares of Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings’s largest shareholders are Ra capital management (7.81M shares, 25.93%), Novo (4.18M shares, 13.88%), and Fmr (3.72M shares, 12.36%). Together, they hold 52.18% of Hemab Therapeutics Holdings’s total shares outstanding.

Does Blackrock own Hemab Therapeutics Holdings?

BlackRock is not among the top 10 institutional shareholders of Hemab Therapeutics Holdings.

Who is Hemab Therapeutics Holdings’s biggest shareholder by percentage of total assets invested?

Novo is Hemab Therapeutics Holdings’s biggest shareholder by percentage of total assets invested, with 8.92% of its assets in 4.18M Hemab Therapeutics Holdings shares, valued at 153.55M$.

Who is the top mutual fund holder of Hemab Therapeutics Holdings shares?

American Funds SMALLCAP World A is the top mutual fund holder of Hemab Therapeutics Holdings shares, with 7.51% of its total shares outstanding invested in 3.51M Hemab Therapeutics Holdings shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools